Target intelligence / Profile preview

Melanoma-associated antigen F1 (MAGEF1)

Target
MAGEF1
Molecular classification
E3 ubiquitin ligase adapter, Cancer/testis antigen, MAGE family protein
01

Overview

Melanoma-associated antigen F1 (MAGEF1) is a member of the MAGE protein family, defined by the conserved MAGE homology domain. MAGEF1 acts as a substrate adapter and enhancer for E3 ubiquitin ligase complexes, particularly promoting proteasomal degradation of key regulatory proteins such as MMS19, with downstream impacts on DNA repair and genome stability. Aberrant expression of MAGEF1 is associated with several cancers, most notably melanoma, making it a key cancer/testis antigen and a candidate target for immunotherapy and novel anticancer agents. MAGEF1 is evolutionarily conserved, and its biological roles are being elucidated in the context of ubiquitin-mediated proteostasis and DNA repair regulation.

Other names
MAGE family member F1Melanoma-associated antigen F1MAGEF1MAGE-F1MAGE-F1 antigenMelanoma antigen family F, 1Melanoma antigen family F1
02

Mechanism of action

When targeted, mechanisms would likely involve: Small molecules or biological agents blocking substrate binding or disrupting interaction with E3 ligases, thereby altering ubiquitination and proteasomal degradation of specific targets. Immunotherapy approaches aimed at eliciting immune responses against MAGEF1-expressing tumor cells.

03

Biological functions

Enhancing E3 ubiquitin ligase activity (in concert with RING-type E3 ligases, e.g., NSE1)Mediating proteasomal degradation of specific substrates (e.g., MMS19)Regulation of DNA repair processes, notably by inhibiting homologous recombination-mediated double-strand break repairNegative regulation of genome integrityProtein–protein interactions via substrate recruitment/adaptation
04

Disease associations

Cancer (notably melanoma and other tumors where cancer/testis antigens are expressed)Potentially involved in DNA repair disorders via impact on genome stability
05

Safety considerations

MAGE family antigens are normally restricted to germ cells and undetectable in adult somatic tissues, but aberrant expression in somatic cells (such as in tumors) is a hallmark of cancer/testis antigensTherapeutic targeting of MAGEF1 may carry risks of off-target effects on germ cells, but this risk is theoretically lower because outside cancer/testis contexts, expression is limited
06

Interacting drugs

There are currently no well-established drugs that directly target MAGEF1 in clinical use; MAGE family proteins are being explored as immunotherapy targets and as candidates for development of small-molecule inhibitors
07

Biomarkers

Expression of MAGEF1 (and other MAGE family members) is used as a biomarker for the presence of certain cancers, especially melanoma, and for the selection of patients for immunotherapies targeting cancer/testis antigens

Beyond the preview

Go deeper on Melanoma-associated antigen F1 (MAGEF1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Melanoma-associated antigen F1 (MAGEF1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call